Oslomed – Clinical Trial Site Organization
Together We Deliver
Clinical Excellence
for You
Advanced clinical research site specializing in Phase II-IV trials.
ICH-GCP compliant. PRO integration & eICF ready.
Oslomed simplifies clinical trial execution in Poland. We offer sponsors and CROs rapid decisions, efficient recruitment, and high participant retention in Phase II-IV trials — without unnecessary bureaucracy.
We Simplify Clinical Trials from Site Selection to Study Close-Out
Oslomed partners with pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs) as a partner in executing Phase II-IV clinical trials in Poland.
Clinical Trial Execution
From feasibility assessment, through active trial conduct to final documentation handover..
- Feasibility Response – recruitment capability analysis within 24 working hours
- Patient Recruitment – active enrollment strategies
- Site Initiation – team training and operational readinessg
- Trial Conduct – participant care and protocol adherence
- Participant Retention – support programs ensuring trial continuation
- CRA Collaboration – documentation readiness and support during monitoring visits
- Study Close-Out – documentation finalization and archiving
Technology Readiness
Flexible integration with sponsor-selected systems
- Flexible Integration – we work with systems proposed by sponsor/CRO
- EMR Integration Ready - open to electronic medical records
- eICF Implementation – ready to deploy electronic informed consent solutions
- Dedicated IT Infrastructure – stable connectivity
Patient Recruitment: The Biggest Challenge in Clinical Trials
Industry research shows that 80% of clinical trials experience recruitment delays, with the average delay costing sponsors €600,000 to €8 million per month. Moreover, 37% of trial sites consistently under-enroll, and 11% fail to recruit any patients at all—forcing sponsors to activate additional sites and extend timelines.
Oslomed's Solution
Unlike most sites that struggle with recruitment, Oslomed has established direct patient access through our specialized outpatient clinics and comprehensive patient database. Furthermore, our existing patient population across multiple therapeutic areas enables rapid screening and enrollment. Consequently, this approach reduces time-to-first-patient and accelerates study timelines.
How Does Oslomed Solve This Problem?
As a research site integrated with an active specialty clinic, we have direct access to an active patient database with medical history. Therefore, this provides sponsors with predictability and shortens time to first participant.
- Clinic Database – 8,000+ annual visits across 12 medical specialties
- Medical Record Access – rapid candidate pre-screening
- Existing Physician-Patient Relationship – trust facilitates clinical trial enrollment
- Rapid Identification – we analyze our database before launching external campaigns
- Continuity of Care – patients can return to our clinic after trial completion
Therapeutic Areas
Experienced investigators conducting Phase II-IV projects in key therapeutic areas. Team of Principal Investigators and Coordinators with experience in international trials and access to comprehensive diagnostic infrastructure, backed by qualified medical and administrative support staff.
Active Therapeutic Areas
Therapeutic areas with experienced investigators and coordinator teams.
Gastroenterology
Indications: Inflammatory Bowel Disease, Crohn's disease, ulcerative colitis, irritable bowel syndrome.
Dermatology
Indications: Psoriasis (plaque, scalp, palmoplantar), atopic dermatitis, hidradenitis suppurativa, acne vulgaris.
Cardiovascular
Indications: Heart failure (HFrEF/HFpEF), atrial fibrillation, arterial hypertension, dyslipidemia, coronary artery disease.
Rheumatology and Immunology
Indications: Rheumatoid arthritis, psoriatic arthritis, goat, ankylosing spondylitis, systemic lupus erythematosus.
Pulmonology/Respiratory Diseases
Indications: COPD, severe asthma (severe eosinophilic asthma), idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension (PAH).
Neurology
Indications: Alzheimer's disease, Parkinson's disease, sleep disorder, migraine, stroke, peripheral neuropathies, epilepsy.
Oncology
Indications: Breast cancer, NSCLC.
Endocrinology/Metabolic
Indications: Type 2 diabetes (T2DM), diabetic kidney disease (DKD), obesity, thyroid disorders, osteoporosis, neuroendocrine tumors (NET).
Development Areas – Expanding Expertise
Therapeutic areas where we are actively building our Principal Investigator team and adapting our infrastructure through partnerships with clinics. We are expanding our network of collaborating physicians to ensure qualified personnel and enhanced patient recruitment capacity for sponsor projects.
Psychiatry/Mental Health & Psychedelics
Target indications: Major Depressive Disorder, schizophrenia, anxiety disorders, ADHD, bipolar disorder.
Gynecology and Women's Health
Target indications: Endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), menopause, contraception.
Other Therapeutic Areas?
Don't see your therapeutic area? Contact us. We'll assess recruitment possibilities and present an action plan within days.
Contact UsQuality and Trial Oversight
As a small, independent site, we combine personal commitment with rigorous quality control processes. Additionally, every sponsor has direct contact with the principal investigator and coordinator managing their trial. No bureaucracy, no delays.
Our Approach to Quality
At Oslomed, every sponsor has direct contact with the principal investigator and coordinator managing their study. In addition, we answer the phone on the first ring and respond to emails the same day. As a result, problems are solved immediately, not in a few days.
Quality through commitment: Our quality system isn't bureaucratic machinery — it's the work style of a tight-knit, motivated team that treats every trial as a personal priority. Moreover, rapid response, flexibility, and complete transparency are our natural advantages.
How Our Site Delivers Quality
Data and Documentation Quality
- First, we enter visit data into electronic data capture systems within 48 hours and respond to data queries within 48 hours.
- Next, we cross‑check key variables and endpoints against the patient's source records before closing each visit.
- Additionally, we confirm informed consent, inclusion/exclusion criteria completeness of visit documentation at screening and every visit.
- Finally, we document all concomitant medications and adverse events in source notes and the database before finalizing each visit.
Participant Safety and Compliance
- Primarily, we report adverse events within 24 hours and serious adverse events immediately, following the protocol and regulations.
- Furthermore, we provide immediate support for study participants with clear escalation paths to investigators.
- Lastly, we maintain inspection readiness with checklists, internal spot checks, and corrective–preventive actions when needed.
Standard Operating Procedures
Written procedures covering:
- Informed consent process
- Participant screening and recruitment
- Investigational product management
- Adverse event reporting
- And more — a complete suite of additional critical SOPs
Regular reviews, version control, training documentation
Clinical Trial Lifecycle at Oslomed
Investigator and Coordinator Team
Our team consists of principal investigators with habilitated doctor and professor titles and experienced research coordinators with current GCP training certificates. Every team member regularly participates in clinical trial conduct training.
Small Site, Big Commitment
Quality control, personal commitment, immediate response. We answer the phone on the first ring. No delays. No unnecessary management layers.
Contact UsContact Us
Are you a sponsor or CRO interested in collaboration?
Contact our clinical trials team.
How Can We Help?
Business Hours
Monday – Friday: 9:00 AM – 8:00 PM
Saturday – Sunday: Closed
We respond to email inquiries within 24 business hours
SEO Keywords
Clinical trials: clinical trials Krakow, clinical trial site Poland, clinical research center Poland, sponsor collaboration, pharmaceutical trials, ICH-GCP, FDA trials, EMA clinical trials, trial site Poland
Recruitment and processes: patient recruitment clinical trials, clinical trial feasibility, site selection, phase II III IV trials, multicenter trials, trial monitoring, patient enrollment, patient retention, clinical trial screening
Specialists and trials: dermatologist clinical trials, cardiologist clinical trials, gastroenterologist clinical trials, rheumatologist clinical trials, pulmonologist clinical trials, neurologist clinical trials, urologist clinical trials, endocrinologist clinical trials, gynecologist clinical trials, orthopedist clinical trials, oncologist clinical trials, diabetologist clinical trials, allergist clinical trials
Therapeutic areas: dermatology trials, cardiology trials, gastroenterology trials, rheumatology trials, pulmonology trials, neurology trials, urology trials, endocrinology trials, gynecology trials, orthopedic trials, oncology trials, diabetology trials, allergology trials
Disease units - dermatology: psoriasis clinical trials, atopic dermatitis trials, acne clinical trials, vitiligo trials, AD clinical trials
Disease units - cardiology: hypertension trials, atrial fibrillation trials, coronary artery disease trials, heart failure trials
Disease units - gastroenterology: Crohn's disease clinical trials, ulcerative colitis trials, UC trials, gastroesophageal reflux trials, IBD clinical trials
Disease units - rheumatology: rheumatoid arthritis trials, RA clinical trials, ankylosing spondylitis trials, AS trials, psoriatic arthritis trials, lupus clinical trials
Disease units - pulmonology: asthma clinical trials, COPD clinical trials, idiopathic pulmonary fibrosis trials, cystic fibrosis trials
Disease units - neurology: Parkinson's disease trials, multiple sclerosis clinical trials, MS trials, epilepsy clinical trials, Alzheimer's disease trials, migraine clinical trials
Disease units - other: type 2 diabetes trials, benign prostatic hyperplasia trials, endometriosis clinical trials, osteoarthritis trials, osteoporosis clinical trials, obesity clinical trials
Compliance and regulations: investigational product, informed consent, adverse events, safety monitoring, regulatory compliance, good clinical practice, clinical trial documentation, clinical trial audits, pharmacokinetics
Technology and partners: biotechnology, principal investigator, clinical trial coordinator, CRO Poland, drug development, post-marketing trials